Lenox Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Lenox Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$71K	Hold	130	–	–	0.01%	201
2021 Q4	$86K	Hold	130	–	–	0.01%	182
2021 Q3	$81K	Hold	130	–	–	0.01%	175
2021 Q2	$82K	Hold	130	–	–	0.01%	168
2021 Q1	$64K	Hold	130	–	–	0.01%	159
2020 Q4	$65K	Hold	130	–	–	0.01%	161
2020 Q3	$51K	Hold	130	–	–	0.01%	161
2020 Q2	$43K	Hold	130	–	–	0.01%	177
2020 Q1	$31K	Hold	130	–	–	0.01%	189
2019 Q4	$34K	Buy	+130	New	+$34.3K	0.01%	234
2018 Q2	–	Sell	-407	Closed	-$78K	–	595
2018 Q1	$78K	Buy	+407	New	+$75.1K	0.02%	124

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Lenox Wealth Advisors's IDXX Position: Q1 2022 in Review

Lenox Wealth Advisors held its Idexx Laboratories (IDXX) position steady in Q1 2022 at 130 shares worth $71K. The position accounts for 0.01% of the portfolio, ranked #201.

Lenox Wealth Advisors first reported a position in IDXX in Q1 2018 and has held it in 11 quarters since. The position peaked at $86K in Q4 2021. 1,033 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Lenox Wealth Advisors held 130 shares of Idexx Laboratories worth $71K as of Q1 2022.
Lenox Wealth Advisors left its Idexx Laboratories share count unchanged in Q1 2022.
Idexx Laboratories made up 0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #201 holding.
Lenox Wealth Advisors first reported a position in Idexx Laboratories in Q1 2018 and has held it in 11 quarters since.
Lenox Wealth Advisors's Idexx Laboratories position peaked at $86K in Q4 2021.
1,033 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.